News

Expand filters

Filters

Services

Showing 1 - 8 out of 8 results

Article

Health News You Can Use: Perimenopause

Perimenopause is the transition between reproductive age and menopause, which can last several years and affect physical, emotional, mental and social well-being.

Patient Stories

A Heart Care Experience to Remember: For a Kansas Citian With a History of Heart Issues, the Proactive, Personable Care at Saint Luke’s Stood Out

Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.

News

FOX 4: Saint Luke's Physician Shares Insights on Perimenopause During Women's Health Week

Learn more about signs and symptoms of perimenopause, navigating treatment, and how your women's health provider can help in this segment with Bret Gordon, DO, division chair at Saint Luke’s Women’s Health South.

News

KSHB: Oklahoma Family Travels to Kansas City to Receive Lifesaving Heart Procedure

Chandler DeBolt needed immediate attention but had extremely limited options before his family was referred to the Adult Congenital Heart Disease program at Saint Luke’s Mid America Heart Institute in Kansas City.

Study Led by Saint Luke’s Mid America Heart Institute Finds Widespread Evidence of Heart Disease in Ancient Mummies Around the World

Largest systematic study of atherosclerosis in ancient human remains suggests innate human predisposition to heart disease.

News

Allen County Regional Hospital Auxiliary Approved Funding for Ultrasound Probe

The new ultrasound probe, which will primarily be used in the hospital's emergency department, provides a detailed view of what's happening in a patient's body in real-time.

News

Cardiovascular Business: SPECT Still Has an Important Role to Play in Nuclear Cardiology

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

News

Cardiovascular Business: Flurpiridaz Will Have a Major Impact on Cardiac PET and Nuclear Imaging

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.